Finance

Beta
Lists
GRTX:OTCMKTS
Galera Therapeutics Inc
$0.085
-4.66%
(-0.0041) 1D
Jun 11, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for GRTX...
Open
$0.08
High
$0.09
Low
$0.08
Mkt. cap
17.11M
Avg. vol.
94.18K
Volume
10.46K
P/E ratio
0.13
52-wk high
$0.15
52-wk low
$0.02
EPS
$0.64
Beta
2.59
Shares outstanding
160.43M
No. of employees
3
Open
$0.08
High
$0.09
Low
$0.08
Mkt. cap
17.11M
Avg. vol.
94.18K
Volume
10.46K
P/E ratio
0.13
52-wk high
$0.15
52-wk low
$0.02
EPS
$0.64
Beta
2.59
Shares outstanding
160.43M
No. of employees
3
News stories
From sources across the web
About Galera Therapeutics Inc
CEO-
Employees3
Founded2012
HeadquartersMalvern, Pennsylvania, United States
SectorBiotechnology
Websitegaleratx.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
84.00K
130.00K
42.00K
15.00K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.05M
1.31M
1.47M
1.64M
Operating expense
1.14M
1.44M
1.51M
1.66M
Total operating expenses
1.14M
1.44M
1.51M
1.66M
Operating income
-1.14M
-1.44M
-1.51M
-1.66M
Other non operating income
-
-
-
-
EBT including unusual items
-1.08M
-1.39M
153.10M
-1.61M
EBT excluding unusual items
-1.08M
-1.39M
-1.44M
-1.61M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-1.08M
-1.39M
153.10M
-1.61M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
60.00K
48.00K
63.00K
49.00K
Interest expense
-
-
-
-
Net interest expenses
60.00K
48.00K
63.00K
49.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-1.13M
-1.43M
-1.50M
-
Gain or loss from assets sale
-
-
-3.50M
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer